new post
StocksRunner logo
mail
search
 
menu
 
NovoCure Limited Ord
$12.63
+20.29%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

NVCR Stock Analysis & IQ Rating | NovoCure Limited Ord

 
 

NVCR

 

NovoCure Limited Ord

$12.63

 
+$2.13 | +20.29%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$22.95
 
 
MKT CAP
$1.41B
 
52W Low
$9.82
 
 
VOL
$14.25M
 
P/E Ratio
N/A
 
 
AVG VOL
$1.42M
 
RSI
54.05
 
 
TREND
Sideways
 
 
 

NVCR Stock IQ

 
lock  Login to see NovoCure Limited Ord (NVCR) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

NVCR Target Price

 
 
 
 

NVCR Price Performance

 
 

$13.8   (-8.48%)

$11.27   (+12.07%)

$12.69   (-0.47%)

$19.07   (-33.77%)

 
 
1year
6month
3month
1month
 

NVCR Analysts Opinion

 

Overall standing based on market and analyst consensus. menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 

NVCR Earnings Sentiment

 Revenue declined YoY

 
 

Rating

×
 

Rating

 
 

Momentum

×
 

Momentum

 

NVCR Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

 
 

Future

×
 

Future

 
 
 

NVCR Analysts Opinion

NVCR Analysts opinion is negative and it remained unchanged from the past 3 months

 

NVCR Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
77%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
100%
100%
 

NVCR Street Sentiment 

NVCR Street Sentiment is unimpressive and have negative views on the near-term outlook

 

NVCR Risk Level

 
 

NVCR has Low risk level

 
 
 
NVCR Risk Level
Low
LOW
HIGH
 

NVCR Performance Sentiment

 
Sentiments overview associated with events and the stock performance
 
 
77%
15%
Positive
Negative
10 out of 13
events present
2 out of 13
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Key Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$10.50
 
Resistance
Price
 
$10.03
 
 
Current Price Range
 
$14.87
 
 
Show methods +
 
 
NVCR Latest Analysis +
 
 
FAQ About NVCR Stock Insights
 

What is NVCR current stock price?

What are NVCR stock strengths?

What is NVCR Risk Level?

What is NVCR market cap and volume?

What is NVCR current Stock IQ?

Should I buy NVCR stock right now?

Is NVCR a Strong Buy right now?

What does a 'Strong Buy' rating mean for NVCR?

What does a 'Strong Sell' rating mean for NVCR?

What factors influence NVCR's Stock IQ?

 
 
StocksRunner

Explore our NVCR Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored NVCR Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our NVCR Daily Alerts

Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

NVCR

 

NovoCure Limited Ord

 
Set Alerts
 
 

Current Price

 

$12.63

 
+$2.13 | +20.29%
 
 
52W High
$22.95
 
 
MKT CAP
$1.41B
 
52W Low
$9.82
 
 
VOL
$14.25M
 
P/E Ratio
N/A
 
 
AVG VOL
$1.42M
 
RSI
54.05
 
 
TREND
Sideways
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 
user
 
 
 
 

NVCR Price Performance

 
 

$13.8   (-8.48%)

$11.27   (+12.07%)

$12.69   (-0.47%)

$19.07   (-33.77%)

 
 
1year
6month
3month
1month
 

NVCR Analysts Opinion

 

Overall standing per market and analyst expectations. menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 

NVCR Earnings Sentiment

 Revenue declined YoY

 
 

Rating

×
 

Rating

 
 

Momentum

×
 

Momentum

 

NVCR Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

 
 

Future

×
 

Future

 
 
 

NVCR Analysts Opinion

NVCR Analysts opinion is negative and it remained unchanged from the past 3 months

 

NVCR Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
77%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
100%
100%
 

NVCR Street Sentiment 

NVCR Street Sentiment is unimpressive and have negative views on the near-term outlook

 

NVCR Risk Level

 
 

NVCR has Low risk level

 
 
 
NVCR Risk Level
Low
LOW
HIGH
 
NVCR Performance Sentiment
 
Sentiments overview associated with events and the stock performance.
 
 
77%
15%
Positive
Negative
10 out of 13
events present
2 out of 13
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Key Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$10.50
 
Resistance
Price
 
$10.03
 
 
Current Price Range
 
$14.87
 
 
Show methods +
 
 
 
 
 
 

NVCR Stock IQ

 
 
 
lock  Login to unlock NovoCure Limited Ord (NVCR) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 

Not Enough Information

 
 
 

NVCR Latest Analysis

 
 
 

NovoCure Stock Surges After FDA Approves Optune Pax. ) shares are popping on Thursday following a major FDA approval that sent the stock soaring nearly 30% .NovoCure stock is showing exceptional strength. After the close Wednesday the FDA approved Optune Pax for the treatment of locally advanced pancreatic cancer — marking the first new treatment for the disease in almost 30 years.CEO The decision was supported by results from the PANOVA‑3 Phase 3 trial which compared Optune Pax plus chemotherap

 

Today

$12.63 | +20.29%
 
Activity
Momentum

NovoCure Shares Surge 34% Over FDA Approval For Optune Pax . (RTTNews) - Stock of NovoCure Limited (NVCR) is rising about 34 percent during Thursday morning trading following the United States FDA approval of Optune Pax for adult patients with locally advanced pancreatic cancer in combination with gemcitabine and nab-paclitaxel.

 

Today

$12.63 | +20.29%
 
Activity
Momentum

Novocure shares surge after FDA approves Optune Pax for pancreatic cancer.

 

Today

$12.63 | +20.29%
 
Activity
Momentum

Novocure Stock Soars On FDA Approval Of Optune Pax For Pancreatic Cancer . (RTTNews) - Novocure (NVCR) announced that the United States FDA has approved Optune Pax for adult patients with locally advanced pancreatic cancer in combination with gemcitabine and nab-paclitaxel.

 

Today

$12.63 | +20.29%
 
Activity
Momentum

NovoCure Enters Oversold Territory (NVCR). Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me

 

Thu Feb 5, 2026

$10.09 | -12.72%
 
Technical
Technical

NovoCure projects $13M monthly revenue hit as Medicare revokes billing privileges.

 

Thu Feb 5, 2026

$10.09 | -12.72%
 
Earnings
 
 
 
 
 
StocksRunner

Discover NVCR Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of NVCR. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our NVCR Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

NVCR Stock trends

NVCR Stock performance

NVCR Stock analysis

NVCR investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

NVCR Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing NVCR

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing NVCR

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.